Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/1998
03/24/1998US5731332 Leukotriene antagonists; antiinflammatory agents, antiallergens
03/24/1998US5731331 Tetrahydropyridine-(or 4-hydroxypiperidine) alkylazoles
03/24/1998US5731328 Administering 2-phenyl-3-aroylbenzothiophene compounds to a patient
03/24/1998US5731327 Synthesis of 3- 4-(2-aminoethoxy)benzoyl!-2-aryl-6-hydroxybenzo b!thiophenes
03/24/1998US5731326 Platelet derived growth factor
03/24/1998US5731321 Endothelin receptor antagonists
03/24/1998US5731315 Inhibitors of factor xa
03/24/1998US5731309 Asthma
03/24/1998US5731306 Mercaptoacetylamido 1,3,4,5-tetrahydro-benzo c!azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace
03/24/1998US5731299 Phosphonosulfonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
03/24/1998US5731293 Enzyme inhibitors
03/24/1998US5731289 Bridged dipeptide compounds which have a stimulating activity on cell division, especially in myelopoietic and bone marrow cells
03/24/1998US5731286 Cyclic neurokinin A antagonists
03/24/1998US5731170 DNA encoding a growth factor specific for epithelial cells
03/24/1998US5731028 Crystallized zilpaterol hydrochloride
03/24/1998US5731007 Pharmaceutical composition for skin diseases
03/24/1998US5730980 Methods and compositions for ameliorating the symptoms of sepsis
03/24/1998US5730975 Treatment of insulin resistance in obesity linked type II diabetes using antagonist to TNF-alpha function
03/24/1998US5730971 Mixture of flavin adenine dinucleotide and porcien liver extract
03/24/1998CA2214919A1 Benzothiophene compounds, intermediates, processes, compositions, and methods
03/24/1998CA2211008A1 Nucleic acid constructs containing hybrid promoters for use in gene therapy
03/24/1998CA2129037C Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers
03/24/1998CA1339777C Superoxide dismutase polymers
03/24/1998CA1339776C Equine-gamma-interferon
03/24/1998CA1339770C Mitotic inhibitor and method for preventing posterior lens capsule opacification after extracapsular extraction
03/20/1998CA2185950A1 Process for preparing intermediates for thrombin inhibitors
03/19/1998WO1998011243A2 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein
03/19/1998WO1998011225A2 A novel haemopoietin receptor and genetic sequences encoding same
03/19/1998WO1998011206A2 THERAPY FOR α-GALACTOSIDASE A DEFICIENCY
03/19/1998WO1998011135A1 A taxol-like protein (talp) and process for preparing the same
03/19/1998WO1998011128A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production
03/19/1998WO1998011119A1 Novel pyranoside derivatives
03/19/1998WO1998011110A1 3-substituted pyrido[4',3':4,5]thieno[2,3-d]pyrimidine derivatives, their preparation and their use
03/19/1998WO1998011109A1 Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes
03/19/1998WO1998011096A1 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
03/19/1998WO1998011092A1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors
03/19/1998WO1998011086A1 Chromone derivatives and nerve cell death inhibitors containing the same
03/19/1998WO1998011068A1 D4 receptor selectivity piperazine derivatives
03/19/1998WO1998011067A1 Preparation of 1-butyl-4-piperidinylmethylamine
03/19/1998WO1998011066A1 Polydithiocarbamate-containing macromolecules and the use thereof for therapeutic and diagnostic applications
03/19/1998WO1998010792A1 Immune direction therapy
03/19/1998WO1998010787A2 Pharmaceutical compositions for the treatment of immune disorders
03/19/1998WO1998010783A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions
03/19/1998WO1998010782A1 Antifungal combination therapy
03/19/1998WO1998010780A1 ISOLATED PEPTIDES WHICH COMPLEX WITH HLA-Cw*16 MOLECULES, AND USES THEREOF
03/19/1998WO1998010778A1 INHIBITION OF APOPTOSIS USING INTERLEUKIN-1β-CONVERTING ENZYME (ICE)/CED-3 FAMILY INHIBITORS
03/19/1998WO1998010775A1 Composition and method for repairing neurological tissue
03/19/1998WO1998010766A1 METHOD OF INHIBITING BIOSYNTHESIS OF EIf5A
03/19/1998DE19637237A1 Piperazin-Derivate Piperazine derivatives
03/19/1998DE19637123A1 Neue Pyranosidderivate New Pyranosidderivate
03/19/1998CA2265885A1 Pharmaceutical compositions for the treatment of immune disorders
03/19/1998CA2265877A1 Polydithiocarbamate-containing macromolecules and the use thereof for therapeutic and diagnostic applications
03/19/1998CA2265509A1 3-substituted pyrido(4',3':4,5)thieno(2,3-d)pyrimidine derivatives, their preparation and their use
03/19/1998CA2264966A1 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein
03/19/1998CA2264748A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions
03/19/1998CA2264563A1 Isolated peptides which complex with hla-cw*16 molecules, and uses thereof
03/19/1998CA2264541A1 Human protein kinases
03/19/1998CA2262818A1 Modified amino acids, pharmaceuticals containing these compounds and methods for their production
03/19/1998CA2237314A1 Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes
03/18/1998EP0829481A1 Morphinan hydroxamic acid compounds
03/18/1998EP0829480A2 Tetrazolyl-substituted quinuclidines as substance P antagonists
03/18/1998EP0829263A1 Use of 8,9-dehydroestrone in estrogen therapy
03/18/1998EP0829261A2 Composition comprising isoflavone or derivatives thereof for promoting fat-degradation in fat-cells
03/18/1998EP0828854A1 Analytical and therapeutic agents
03/18/1998EP0828849A1 High-affinity oligonucleotide ligands to growth factors
03/18/1998EP0828843A1 Recombinant heregulins and their biological functions upon receptor activation
03/18/1998EP0828833A1 Chemokine n-terminal deletion mutations
03/18/1998EP0828831A2 A novel human purinergic p 2u? receptor
03/18/1998EP0828758A1 Chimeric fatty body-pro-grf analogs with increased biological potency
03/18/1998EP0828754A1 Dipeptides which promote release of growth hormone
03/18/1998EP0828746A1 Novel quinoxaline dione derivatives, their production and their use in medicaments
03/18/1998EP0828742A1 Diazepino-indoles as phosphodiesterase iv inhibitors
03/18/1998EP0828737A1 Isoxazoline and isoxazole derivatives as integrin receptor antagonists
03/18/1998EP0828732A1 Peptidyl compounds and their therapeutic use
03/18/1998EP0828730A1 Piperazine derivatives
03/18/1998EP0828728A1 Phenyl dihydrobenzofuranes
03/18/1998EP0828727A1 Cyclohexyl dihydrobenzofuranes
03/18/1998EP0828726A1 Tricyclic inhibitors of matrix metalloproteinases
03/18/1998EP0828724A1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors
03/18/1998EP0828721A1 2-amino-benzoxazinones for the treatment of viral infections
03/18/1998EP0828508A2 Compositions of interleukin and pyrimidine nucleosides
03/18/1998EP0828505A1 Use of angiotensin ii type 2 receptor agonists in tissue repair
03/18/1998EP0828504A2 Method for treating huntington's disease using glial cell line-derived neurotrophic factor (gdnf) protein product
03/18/1998EP0828500A1 Use of flavanolignanes for the preparation of medicaments with antiproliferative activity in uterus, ovary and breast
03/18/1998EP0828496A1 Use of alendronate for the prevention of osteoporosis
03/18/1998EP0828493A1 4.4-(disubstituted)cyclohexan-1-ols-monomers and related compounds
03/18/1998EP0828490A1 RAR-beta SELECTIVE RETINOID COMPOUNDS FOR INHIBITING GENE EXPRESSION PROMOTED BY AP1 PROTEIN AND THEIR USE IN THERAPY
03/18/1998EP0828483A1 Use of tropolone derivatives as inhibitors of the enzyme inositol monophosphatase
03/18/1998EP0828418A1 Inducement of thermotolerance with benzoquinonoid ansamycins
03/18/1998EP0674638B1 Substituted triols
03/18/1998EP0619734B1 New pharmaceutical formulations of 5-(2-chloro-1-hydroxyethyl)-4-methylthiazole
03/18/1998EP0563329B1 Angiogenic peptides
03/18/1998EP0535148B1 Stimulation of bone marrow stromal and progenitor cells
03/18/1998CN1176648A A method of identifying CFTR-binding compounds useful for activating chloride conductance in animal cells
03/18/1998CN1176645A Compounds with growth hormone releasing properties
03/18/1998CN1176640A Inhibitors of microsomal triglyceride transfer protein and mothed
03/18/1998CN1176603A Vascular endothelial growth factor-B
03/18/1998CN1176601A Quinazolinone-containing pharmaceutical compositions and methods for the use thereof
03/18/1998CN1176104A Sucking dog capsule and its production process
03/18/1998CN1176102A Use of nonpeptide bradykinin antagonists for treatment and prevention of chronic fibrogenetic liver disorders acute liver disorders and complications associated therewith
1 ... 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 ... 1564